Home > PE Ratio > ERIS LIFESCIENCES

ERIS LIFESCIENCES
PE (Price/Earnings) Ratio

The Current P/E Ratio of ERIS LIFESCIENCES is 51.05.

Share Price ₹1,376.2Nov 22,2024
Market Cap ₹18,729.4 Cr
Earnings-TTM₹366.9 CrTTM-Consolidated Results
Price/Earnings51.05xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ERIS LIFESCIENCES
Please provide your vote to see the results
ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of ERIS LIFESCIENCES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ERIS LIFESCIENCES is calculated as :

Current Market Cap [ ₹18,729.4 Cr] as on Nov 22,2024

(/) Earnings [ ₹366.9 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 51.05x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ERIS LIFESCIENCES , the investors are currently willing to pay 51.05 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ERIS LIFESCIENCES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ERIS LIFESCIENCES over the last five years.

Historical PE (Price/Earnings) ratio chart of ERIS LIFESCIENCES


PE Ratio Performance Analysis for ERIS LIFESCIENCES

- ERIS LIFESCIENCES 's latest p/e ratio is 51.05x.

- ERIS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 22.52x.

- ERIS LIFESCIENCES 's operated at median p/e ratio of 23.06x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ERIS LIFESCIENCES 's p/e ratio peaked in Mar2024 at 29.19x.

- ERIS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2020 of 16.88x.


How does ERIS LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ERIS LIFESCIENCES 366.8651.0518,729.4
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5038.73431,352.0
CIPLA LTD4,485.2226.76120,035.0
DR REDDYS LABORATORIES LTD5,406.8018.73101,286.0
ZYDUS LIFESCIENCES LTD4,298.9022.2195,461.4
DIVIS LABORATORIES LTD1,836.0086.75159,265.0
MANKIND PHARMA LTD2,124.8648.11102,231.0
TORRENT PHARMACEUTICALS LTD1,802.0059.55107,306.0
LUPIN LTD2,651.9435.6194,430.6
AUROBINDO PHARMA LTD3,598.8319.7571,069.8
ABBOTT INDIA LTD1,284.6645.8258,859.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ERIS LIFESCIENCES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.73x
Max industry PE 86.75x
Median industry PE 38.73x
Average industry PE 41.19x



You may also like the below Video Courses